| | | 58451 | | 06.11.2009 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Galvumet 50/500 | Filmtabletten | Coated tablets (Vildagliptinum 50 mg, Metformin Hydrochloride 500 mg) | A10BD08 | CI | | 02 | Galvumet 50/850 | Filmtabletten | Coated tablets (Vildagliptinum 50 mg, Metformin Hydrochloride 850 mg) | A10BD08 | CI | | 03 | Galvumet 50/1000 | Filmtabletten | Coated tablets (Vildagliptinum 50 mg, Metformin Hydrochloride 1000 mg) | A10BD08 | CI |
|
|
